Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Uganda: Emphasising evidence-based prevention technologies a better deal

On World AIDS Day President Yoweri Museveni told Ugandan youth to fight AIDS by not having sex and blamed evidence-based prevention interventions, in particular, condoms and medical male circumcision on Uganda’s troubled AIDS response. He also said becoming HIV-positive brings shame to a family. These off-the-cuff comments cause more harm than good.

Published
10 December 2014
From
New Vision
Will AbbVie's 3-DA regimen prove a compelling competitor to Gilead's Harvoni?

Later this month, the FDA is expected to approve AbbVie's oral '3-DA' product - comprising Viekirax (ombitasvir/ paritaprevir/ ritonavir) plus Exviera (dasabuvir) - for the treatment of genotype 1 hepatitis C patients. European approval is expected to occur in early 2015 following a positive recommendation from a European Medicines Agency committee last month. Payers in the US are hoping that AbbVie will deliver festive cheer by announcing a notable 'sticker price' discount versus Gilead Sciences' Harvoni brand, which costs $94,500 for a 12-week supply.

Published
10 December 2014
From
Hepatitis C New Drugs
Sophisticated HIV diagnostics adapted for remote areas

Diagnosing HIV and other infectious diseases presents unique challenges in remote locations that lack electric power, refrigeration, and appropriately trained health care staff. To address these issues, researchers have developed a low-cost, electricity-free device capable of detecting the DNA of infectious pathogens, including HIV-1.

Published
10 December 2014
From
Science Daily
HIV dollars drop with waning philanthropic funds

Last year saw the lowest level of funding from charitable donors since 2007, the year when government spending on HIV began to drop. While the report notes that philanthropic support accounted for just three percent of all international funding for HIV-related efforts in low and middle-income countries, it has increasingly been cited in recent years as a source of support to fill gaps left by constricting national budgets.

Published
10 December 2014
From
Science Speaks
PEPFAR’s ‘Global Pediatric ARV Commitment-To-Action’ Aims To Improve Drug Access

Since the start of President Obama’s Administration, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) has achieved a four-fold increase and is now providing 7.7 million people with life-saving antiretroviral (ARV) treatment worldwide. Despite this, only 1 in 4 of the 3.2 million children living with HIV/AIDS worldwide are today receiving treatment.

Published
09 December 2014
From
US Department of State
The Most Celebrated, Mistrusted Little Pill in the World

AIDS activists Sean Strub and Peter Staley have been in opposite camps for the past several years. This was the first time the pair had met face to face to discuss PrEP, and their conversation was intense, passionate and sometimes stinging. The men love each other dearly, and yet they, too, have been swept up in the controversy.

Published
07 December 2014
From
Huffington Post
Appeal to global donors to save the Treatment Action Campaign

Fulfilling the right to health depends on common purpose between researchers, clinicians, and activists. On the eve of World AIDS Day 2014 (Dec 1), we write this letter as scientists and academics who are concerned about the possible closure of the Treatment Action Campaign (TAC) in South Africa as a consequence of serious funding difficulties.

Published
05 December 2014
From
The Lancet
European HIV response "falling behind" as Eastern European epidemic grows

HIV diagnoses have increased by 80% in the European region since 2004, and three quarters of new HIV diagnoses in the European region are occurring in Eastern

Published
05 December 2014
By
Keith Alcorn
Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries

The license being granted to Mylan extends to 112 countries, which together account for more than 30 million people living with HIV, representing 84% of those infected globally.

Published
04 December 2014
From
Mylan press release
South Africa: Should HIV Testing Become a Standard Medical Procedure?

Knowing your status is the key to ending the Aids pandemic but still too few South Africans take the step to get tested for HIV. A report in the Mail & Guardian this week less than a third of the country's 35-million sexually active people get tested for HIV annually.

Published
03 December 2014
From
AllAfrica.com

Filter by country